Matsumoto Jiro | Tokyo New Drug Research Laboratories Ii Pharmaceutical Division Kowa Company Ltd.
スポンサーリンク
概要
- MATSUMOTO Jiroの詳細を見る
- 同名の論文著者
- Tokyo New Drug Research Laboratories Ii Pharmaceutical Division Kowa Company Ltd.の論文著者
関連著者
-
Matsumoto Jiro
Tokyo New Drug Research Laboratories Ii Pharmaceutical Division Kowa Company Ltd.
-
Takizawa Toshiaki
Tokyo New Drug Research Laboratories Ii Pharmaceutical Division Kowa Company Ltd.
-
Takizawa Toshiaki
興和
-
Takizawa Toshiaki
岐阜薬科大学 薬理
-
MATSUMOTO Jiro
Tokyo New Drug Research Laboratories II, Pharmaceutical Division, Kowa Company Ltd.
-
Kanke Toru
興和
-
Wada Yasushi
Tokyo Research Laboratories Pharmaceutical Division Kowa Company Ltd
-
Saito Naohiro
Tokyo New Drug Research Laboratories Ii Pharmaceutical Division Kowa Company Ltd.
-
KANKE Toru
Tokyo New Drug Research Laboratories, Kowa Company Limited
-
TAMIYA Masaki
Tokyo New Drug Research Laboratories II, Pharmaceutical Division, Kowa Company Ltd.
-
SAITO Naohiro
Tokyo New Drug Research Laboratories II, Pharmaceutical Division, Kowa Company Ltd.
-
KAWAGOE Junichi
Tokyo New Drug Research Laboratories II, Pharmaceutical Division, Kowa Company Ltd.
-
Timmerman Henk
Leiden/amsterdam Center For Drug Research Division Of Medicinal Chemistry Vrije University
-
Kanke Toru
Tokyo New Drug Research Laboratories Ii Pharmaceutical Division Kowa Company Ltd.
-
Kawagoe Junichi
Tokyo New Drug Research Laboratories Ii Pharmaceutical Division Kowa Company Ltd.
-
Kawagoe Junichi
興和東京研究所
-
Tamiya M
Tokyo New Drug Research Laboratories Ii Pharmaceutical Division Kowa Company Ltd.
-
Tamiya Masaki
興和東京研究所
-
Saito Naohiro
興和東京研究所
-
Tamiya Masaki
Tokyo New Drug Research Laboratories Ii Pharmaceutical Division Kowa Company Ltd.
-
Fujii Mikio
Tokyo Research Laboratories Kowa Co. Ltd.
-
Tanaka Hiroyuki
Department Of Pharmacology Gifu Pharmaceutical University
-
Takeda H
Department Of Pharmacology Gifu Pharmaceutical University
-
INAGAKI Naoki
Department of Pharmacology, Gifu Pharmaceutical University
-
NAGAI Hiroichi
Department of Pharmacology, Gifu Pharmaceutical University
-
WADA Yasushi
Tokyo Research Laboratories, Kowa Company Ltd.
-
HARA Takuya
Tokyo New Drug Research Laboratories II, Pharmaceutical Division, Kowa Company Ltd.
-
HATTORI Yukio
Tokyo New Drug Research Laboratories II, Pharmaceutical Division, Kowa Company Ltd.
-
E. MEEK
Centre for Genome Research, The University of Edinburgh
-
J. H.
Centre for Genome Research, The University of Edinburgh
-
D. HUNTER
Department of Physiology and Pharmacology, University of Strathclyde, Stratheclyde Institute for Bio
-
PLEVIN Robin
Department of Physiology and Pharmacology, University of Strathclyde, Stratheclyde Institute for Bio
-
FUJII Mikio
Tokyo Research Laboratories, Pharmaceutical Division, Kowa Company Ltd
-
TAKIZAWA Toshiaki
Toko Research Laboratories, Pharmaceutical Division, Kowa Company, Ltd.
-
MATSUMOTO Jiro
Toko Research Laboratories, Pharmaceutical Division, Kowa Company, Ltd.
-
TOHMA Tsutomu
Toko Research Laboratories, Pharmaceutical Division, Kowa Company, Ltd.
-
KANKE Toru
Toko Research Laboratories, Pharmaceutical Division, Kowa Company, Ltd.
-
WADA Yasushi
Toko Research Laboratories, Pharmaceutical Division, Kowa Company, Ltd.
-
NAGAO Masafumi
Department of Pharmacology, Gifu Pharmaceutical University
-
ZHANG Min-Qiang
Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Vrije University
-
TIMMERMAN Henk
Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Vrije University
-
Plevin Robin
興和東京研究所
-
Plevin Robin
Department Of Physiology And Pharmacology University Of Strathclyde Stratheclyde Institute For Biome
-
Inagaki N
Laboratory Of Pharmacology Department Of Bioactive Molecules Gifu Pharmaceutical University
-
Nagai Hiroichi
Laboratory Of Pharmacology Department Of Bioactive Molecules Gifu Pharmaceutical University
-
E. Meek
Centre For Genome Research The University Of Edinburgh
-
Hara Takuya
Tokyo New Drug Research Laboratories Ii Pharmaceutical Division Kowa Company Ltd.
-
Wada Yasushi
Tokyo Research Laboratories Kowa Co. Ltd.
-
Inagaki Naoki
Department Of Electrical And Computer Engineering Nagoya Institute Of Technology
-
Inagaki Naoki
Department Of Pharmacology Gifu Pharmaceutical University
-
Nagai Hiroichi
Department Of Clinical Pharmacology Gifu Pharmaceutical University
-
Nishida Hiroyuki
Department Of Pharmacology Gifu Pharmaceutical University
-
Fujii Mikio
Tokyo Research Laboratories Pharmaceutical Division Kowa Company Ltd
-
Hattori Yukio
Tokyo New Drug Research Laboratories Ii Pharmaceutical Division Kowa Company Ltd.
-
J. H.
Centre For Genome Research The University Of Edinburgh
-
Ueda Hideo
Sakakibara Heart Institute
-
Takeda Hiroshi
Minase Research Institute Ono Pharmaceutical Co. Ltd.
-
Tanaka Hiroyuki
Laboratory Of Bioresponses And Regulation United Graduate School Of Drug Discovery And Medical Infor
-
Inagaki Naoki
Departmen T Of Pharmacology Gifu Pharmaceutical University
-
Nakamura Masaki
Tokyo Research Laboratories Kowa Co. Ltd.
-
D. Hunter
Department Of Physiology And Pharmacology University Of Strathclyde Stratheclyde Institute For Biome
-
Inagaki Naoki
Laboratory Of Bioresponses And Regulation United Graduate School Of Drug Discovery And Medical Information Science Gifu University
-
Nagai Hiroichi
Department Of Applied Pharmacology Graduate School Of Medicine And Pharmaceutical Sciences University Of Toyama
-
SHIRASAWA Yoshiaki
Tokyo Research Laboratories, Kowa Co., Ltd.
-
Shirasawa Yoshiaki
Tokyo Research Laboratories, Kowa Company Ltd.
-
Iwai Tomoyuki
Tokyo Research Laboratories, Kowa Company Ltd.
-
Matsumoto Jiro
Tokyo Research Laboratories, Kowa Company Ltd.
-
Nakamura Masaki
Tokyo Research Laboratories, Kowa Company Ltd.
著作論文
- Abrogation of Bronchial Eosinophilic Inflammation and Attenuated Eotaxin Content in Protease-Activated Receptor 2-Deficient Mice
- VUF-K-8788,a periphery-selective histamine H1 antagonist with anti-pruritic activities.
- Effect of Protease-Activated Receptor-2 Deficiency on Allergic Dermatitis in the Mouse Ear
- VUF-K-8788, a Periphery-Selective Histamine H_1 Antagonist With Anti-pruritic Activities
- Venous Distensibility in Stroke-Prone SHR at 6 and 15 Weeks of Age---Comparison with Age-Matched WKY---